Patents by Inventor Sebastian P. Assenza

Sebastian P. Assenza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE PREPARATION OF ESCITALOPRAM
    Publication number: 20110065938
    Abstract: A novel method is provided for the manufacture of escitalopram. The method comprises chromatographic separation of the enantiomers of citalopram or an intermediate in the production of citalopram using a chiral stationary phase such as Chiralpak™ AD or Chiralcel™ OD. Novel chiral intermediates for the synthesis of Escitalopram made by said method are also provided.
    Type: Application
    Filed: May 17, 2010
    Publication date: March 17, 2011
    Applicant: H. Lundbeck A/S
    Inventors: Michael B. Sommer, Ole Nielsen, Hans Petersen, Haleh Ahmadian, Henrik Pedersen, Peter Brosen, Fiona Geiser, James Lee, Geoffrey Cox, Olivier Dapremont, Christina Suteu, Sebastian P. Assenza, Shankar Hariharan, Usha Nair
  • CRYSTALLINE COMPOSITION CONTAINING ESCITALOPRAM
    Publication number: 20080305164
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Application
    Filed: August 22, 2008
    Publication date: December 11, 2008
    Applicant: H. LUNDBECK A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza
  • REDUCING CARBOHYDRATE DERIVATIVES OF ADAMANTANE AMINES, AND SYNTHESIS AND METHODS OF USE THEREOF
    Publication number: 20080300390
    Abstract: The present invention relates to reducing carbohydrate derivatives of adamantane amines of Formula A or pharmaceutically acceptable salts, solvates or derivatives thereof, wherein R1, R2, R3, and R4 are together or separately H, F, methyl or lower alkyl, alkenyl, or alkynyl groups, and Z is derived from a mono-, di-, oligo-, or poly-saccharide that originally had an aldehyde carbonyl group. The present invention also relates to processes for the preparation of such adamantane amine derivatives, and uses of such derivatives. The compounds of the present invention are useful in the treatment of infections caused by Gram positive or Gram negative bacteria.
    Type: Application
    Filed: June 24, 2008
    Publication date: December 4, 2008
    Applicant: FOREST LABORATORIES HOLDINGS LIMITED
    Inventors: Sebastian P. Assenza, Nanzhu Shen, Salvatore Iacono, Yuriy B. Kalyan, Peter Viski, Matthew Ronsheim
  • Crystalline composition containing escitalopram
    Patent number: 7420069
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Grant
    Filed: February 7, 2005
    Date of Patent: September 2, 2008
    Assignee: H. Lundbeck A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza
  • Crystalline composition containing escitalopram
    Patent number: 6916941
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: July 12, 2005
    Assignee: H. Lundbeck A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza
  • Crystalline composition containing escitalopram
    Publication number: 20030212128
    Abstract: Crystalline particles of escitalopram oxalate with a particle size of at least 40 &mgr;m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
    Type: Application
    Filed: March 31, 2003
    Publication date: November 13, 2003
    Applicant: H. Lundbeck A/S
    Inventors: Troels Volsgaard Christensen, Ken Liljegren, Michiel Onne Elema, Lene Andresen, Shashank Mahashabde, Sebastian P. Assenza